IL6 and diffuse large B-cell lymphoma: Finally, to further confirm the effects of IL-6 and/or IL-17A on DLBCL cell apoptosis, IL-6 and/or IL-17A neutralizing antibodies were used to block IL-6 and IL-17A mediated signaling.